On October 31, 2025, Anika submitted the third and final module of its Hyalofast PMA to the U.S. Food and Drug Administration (FDA). The PMA includes FastTRACK 24-month data and incorporates ...

Macro and Fundamentals in a Tug-of-War, Aluminum Prices Expected to Hover at Highs in the Short Term] During the night session on November 5, the most-traded SHFE aluminum contract opened lower, ...

Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) ...

Randomized trial data support the use of either TNF or IL-17 inhibitors to treat axial spondyloarthritis, based on patient ...

Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...

Wahed Invest LLC is an established leader in digital investment solutions serving a large global and Middle Eastern investor base. Wahed provides an internal screening process for all KWIN holdings, ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

The World Series brought the rise of secondary pitches to new heights. The desire to pitch away from slug meant a heavy dose ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...

Oral therapy showed dose-dependent increases in progranulin protein levels in both plasma and cerebrospinal fluid; >95% mean increase in progranulin levels in CSF, compared to baseline; favorable ...

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.